Lsd1/prmt6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice

HIGHLIGHTS

• who: Ramachandran Prakasam from the finally at , u00b0C for , minThe DNA was then amplified by using the MyTaq HS Red Mix, x and the human AR pair of primers (AR Q mice: Forward, u2032-CTTCTGGCGTGTGACCGGCG, reverse, u2032-TGAGC TTGGCTGAATCTTCC have published the paper: LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice, in the Journal: (JOURNAL) of 16/02/2022
• what: Leveraging cell lines, mice, and patient-derived specimens, the authors show that androgen receptor co-regulators lysine-specific demethylase 1 (LSD1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.